Event Calendar

Events in September 2022

  • Clinical Considerations for Software and AI/Machine Learning

    Clinical Considerations for Software and AI/Machine Learning


    September 8, 2022

    Innovate smarter and not harder by taking key considerations including when an AI solution may be needed and identifying appropriate research questions and best practices for engineering and deploying the model effectively based on industry and the FDA’s SaMD (Software as a Medical Device) regulation guidance.

    Join Proxima Clinical Research’s subject matter expert, Director of Regulatory Affairs, Isabella Schmitt, MBA, RAC, who will expand on clinical considerations for software and artificial intelligence (AI) and machine learning (ML). For all of those interested in learning about this timely topic, register for this free, in-depth webinar now!

    More information

    Driving Value from Tax: Cash Incentives Available to Texas Life Sciences Companies

    Driving Value from Tax: Cash Incentives Available to Texas Life Sciences Companies


    September 8, 2022

    Join us to learn about Federal and State incentives available for companies in the life sciences industry.

    More information

    2022 BioMedSA Award for Innovation in Healthcare & Bioscience

    2022 BioMedSA Award for Innovation in Healthcare & Bioscience


    September 8, 2022

    The BioMedSA Award for Innovation in Healthcare and Bioscience celebrates local and national innovators in the healthcare and bioscience industry, including patient care, education, research and development, leadership, public policy and medical technology.

    In 2022, the Innovation Award will be presented at a formal dinner in San Antonio, where healthcare and bioscience industry leaders can come together to celebrate healthcare innovation. The dinner will highlight and contribute to the collaborative spirit of the life science industry in San Antonio. Old associations will be rekindled in person and new relationships formed as industry leaders interact during the social hour preceding the dinner and the networking time after the dinner.

    More information

  • UT Austin College of Natural Sciences Technology & Science Career Fair IN PERSON

    UT Austin College of Natural Sciences Technology & Science Career Fair IN PERSON


    September 13, 2022

    The fair offers employers a great opportunity to meet diverse undergraduate and graduate students from all majors, promote your open positions, and build your brand with UT Austin students.

    More information

  • ATC Unplugged: Learning from the Past to Prepare for the Future

    ATC Unplugged: Learning from the Past to Prepare for the Future


    September 14, 2022

    NASA’s Lessons Learned Program was designed to educate new generations of NASA engineers on mistakes of the past in order to prevent future accidents, a lesson that can be taken to heart across industries involving teamwork by highly specialized teams.

    More information

  • Get the Most Bang for Your Benefits

    Get the Most Bang for Your Benefits


    September 15, 2022

    In this Austin Tech Roundtable, experts from Excel Benefits will share advice on how employers can look outside the box to pick and design plans that meet employee needs and promote workforce wellness, while protecting their bottom line.

    More information

  • Redefining Early Stage Investments (RESI) Boston Conference

    Redefining Early Stage Investments (RESI) Boston Conference

    All day
    September 21, 2022 September 23, 2022

    The Redefining Early Stage Investments (RESI) conference series connects start-ups and early-stage investors and strategic channel partners. RESI maximizes fundraising companies’ efforts to find partners who are a fit for their technology and stage of development. RESI is uniquely cross-border and cross-domain, connecting start-ups with 10 categories of global investors across the silos of drugs, devices, diagnostics and digital health (4 Ds). RESI caters to both the earliest stage start-ups, those seeking grants, seed and angel capital, and the early-stage firms who seek series A and B funding. RESI is a unique and powerful tool for sourcing assets and advancing innovation across early-stage life science and healthcare.

    More information

    Institute for Biomedical Entrepreneurship (IBE)

    Institute for Biomedical Entrepreneurship (IBE)


    September 21, 2022

    The IBE is a non-profit celebrating 5 years of helping entrepreneurs accelerate the flow of ideas to the marketplace. The IBE program is a 5 day experiential program that includes a mix of classroom work and hands on project work. Advisors work with participants over the 5 day program to develop and refine their pitch and present to an investor panel on the final day. Since its inception, the IBE has helped over 40 companies launch and over 50 corporate projects see success in the marketplace.

    More information

    UT Austin College of Natural Sciences Technology & Science Career Fair VIRTUAL

    UT Austin College of Natural Sciences Technology & Science Career Fair VIRTUAL


    September 21, 2022

    The fair offers employers a great opportunity to meet diverse undergraduate and graduate students from all majors, promote your open positions, and build your brand with UT Austin students.

    More information

  • Redefining Early Stage Investments (RESI) Boston Conference

    Redefining Early Stage Investments (RESI) Boston Conference

    All day
    September 21, 2022 September 23, 2022

    The Redefining Early Stage Investments (RESI) conference series connects start-ups and early-stage investors and strategic channel partners. RESI maximizes fundraising companies’ efforts to find partners who are a fit for their technology and stage of development. RESI is uniquely cross-border and cross-domain, connecting start-ups with 10 categories of global investors across the silos of drugs, devices, diagnostics and digital health (4 Ds). RESI caters to both the earliest stage start-ups, those seeking grants, seed and angel capital, and the early-stage firms who seek series A and B funding. RESI is a unique and powerful tool for sourcing assets and advancing innovation across early-stage life science and healthcare.

    More information

    2022 iC3 Life Science Summit

    2022 iC3 Life Science Summit


    September 22, 2022 September 23, 2022

    The BioNTX iC³ Life Science Summit serves as the forum where leaders come together to discuss strategy, exhibit the broad spectrum of North Texas bioscience research, and where the latest innovation, products and services can be seen. Attendees range from the startup community through large multinationals representing industry sectors such as biotech, pharmaceuticals, healthcare companies, academic research institutions, innovators, and leaders. Also attending will be business development executives, vendor partners, investors, and talent seeking new opportunities.

    More information

    Biostatistics in IVD Clinical Research – Decoding the Biostatistical Black Box

    Biostatistics in IVD Clinical Research – Decoding the Biostatistical Black Box


    September 22, 2022

    During this webinar, NAMSA’s Principal IVD Biostatistician will examine the benefits of including biostatistics early and often in a clinical trial, provide insight on how to prevent unnecessary delays and walk through two real-world case studies.

    More information

  • Redefining Early Stage Investments (RESI) Boston Conference

    Redefining Early Stage Investments (RESI) Boston Conference

    All day
    September 21, 2022 September 23, 2022

    The Redefining Early Stage Investments (RESI) conference series connects start-ups and early-stage investors and strategic channel partners. RESI maximizes fundraising companies’ efforts to find partners who are a fit for their technology and stage of development. RESI is uniquely cross-border and cross-domain, connecting start-ups with 10 categories of global investors across the silos of drugs, devices, diagnostics and digital health (4 Ds). RESI caters to both the earliest stage start-ups, those seeking grants, seed and angel capital, and the early-stage firms who seek series A and B funding. RESI is a unique and powerful tool for sourcing assets and advancing innovation across early-stage life science and healthcare.

    More information

    2022 iC3 Life Science Summit

    2022 iC3 Life Science Summit


    September 22, 2022 September 23, 2022

    The BioNTX iC³ Life Science Summit serves as the forum where leaders come together to discuss strategy, exhibit the broad spectrum of North Texas bioscience research, and where the latest innovation, products and services can be seen. Attendees range from the startup community through large multinationals representing industry sectors such as biotech, pharmaceuticals, healthcare companies, academic research institutions, innovators, and leaders. Also attending will be business development executives, vendor partners, investors, and talent seeking new opportunities.

    More information

  • TAG presents the MetaVerse for Businesses – Manifesting the Moments that Matter

    TAG presents the MetaVerse for Businesses – Manifesting the Moments that Matter


    September 30, 2022

    Virtual worlds help bridge the gap until the next time you can see a person in real life. We’ll explore the moments that matter and and why this is so important. More information at tagaustin.org

    More information

Check these calendars for other Life Science organization’s events

Austin Technology Council Calendar of Events

https://tinyurl.com/y9zzr6jv

Texas States Small Business Development Center Network Calendar of Events

https://tinyurl.com/ybf68aom

Women in Business Virtual Calendar of Events

View the full list of virtual events.

Temple Health & BioScience District’s (THBD’s) E-Learning Series Webinars Library

https://www.templebioscience.org/elearning/

NAMSA’s Podcasts Calendar of Events

https://namsa.com/resources/podcasts/biocompchatibility-podcast/